Stay Informed

Get email alerts when new recalls match your interests.

Recall data is updated hourly from official government sources. Very recent recalls may not yet appear. About our data sources

About

We make U.S. recall data searchable and accessible for consumers and businesses.

Site

FAQ
Browse by State
Statistics
Recall Classifications
About
Enterprise API

Legal

Privacy Policy
Terms of Service
Report Incorrect Info

Official Sources

FDA Recalls ↗
USDA FSIS ↗
CPSC Recalls ↗
NHTSA Recalls ↗

RSS Feed

Home
/
Brands
/
Orient Pharma Co., Ltd. Yunlin Plant

Orient Pharma Co., Ltd. Yunlin Plant Recalls

All product recalls associated with Orient Pharma Co., Ltd. Yunlin Plant.

Get alerts for this brand

Recall Summary

Total Recalls

Past Year

Class I (Serious)

Most Recent

Jun 2025

Data from FDA, USDA, CPSC, and NHTSA public records. Recall counts vary by company size, industry, and reporting practices. Always check official sources for current information.

Showing 1–2 of 2 recalls

Pitavastatin Tablets 2mg (Orient Pharma) – Impurity Specification Failure (2025)

Failed Impurities/Degradation Specifications.

Class IIILow

FDAJun 11, 2025NJ• Orient Pharma Co., Ltd. Yunlin Plant

Pitavastatin Tablets 1mg (Orient Pharma) – Impurity Specification Failure (2025)

Failed Impurities/Degradation Specifications.

Class IIILow

FDAJun 11, 2025NJ• Orient Pharma Co., Ltd. Yunlin Plant